Our study is the first to demonstrate an increased frequency of terminally differentiated effector CD8+CD28-CD27- cytotoxic T cells among CD8+ T lymphocytes in the lung tissue of patients with COPD. This evidence concerns the gene CD8A and chronic obstructive pulmonary disease.